Literature DB >> 20453545

Features of optical coherence tomography are predictive of visual outcomes after intravitreal bevacizumab injection for diabetic macular edema.

Mi In Roh1, Ji Hyun Kim, Oh Woong Kwon.   

Abstract

PURPOSE: To identify optical coherence tomography (OCT) patterns of diabetic macular edema (DME) predictive of visual outcomes after intravitreal bevacizumab (IVB; Avastin®) injection.
METHODS: We retrospectively examined 56 consecutive eyes that were given IVB injections for DME alongside the preoperative macular OCT data. Using this information, we categorized the eyes into 2 groups: group 1 showing diffuse patterns; group 2 demonstrating cystoid macular edema (CME). RESULT: The mean follow-up period was 11.66 ± 3.98 months. Group 1 eyes gained 0.04 ± 9.27 ETDRS letters (p = 0.984), while group 2 eyes gained 5.79 ± 9.98 ETDRS letters (p = 0.005). Mean macular thickness decreased by 72.79 ± 145.74 μm in group 1 (p = 0.014) and by 223.71 ± 224.52 μm in group 2 (p< 0.001).
CONCLUSION: Patients showing CME upon OCT achieved greater improvements in visual acuity and macular thickness after IVB injection than patients with diffuse macular edema. The type of macular edema shown by OCT may provide an objective guideline in predicting the response of DME to IVB injection.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20453545     DOI: 10.1159/000313820

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  17 in total

1.  Paired responses to intravitreal bevacizumab in diabetic macular edema: predictors of response in the fellow eye.

Authors:  Peter A Karth; Anne Chang; William Wirostko
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-07-20       Impact factor: 3.117

2.  Association between characteristics of foveal cystoid spaces and short-term responsiveness to ranibizumab for diabetic macular edema.

Authors:  Tomoaki Murakami; Kiyoshi Suzuma; Akihito Uji; Shin Yoshitake; Yoko Dodo; Masahiro Fujimoto; Tatsuya Yoshitake; Yuko Miwa; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2018-02-19       Impact factor: 2.447

3.  Optical coherence tomography imaging for diabetic retinopathy and macular edema.

Authors:  John C Buabbud; Motasem M Al-latayfeh; Jennifer K Sun
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

4.  Effect of a single intravitreal bevacizumab injection on different optical coherence tomographic patterns of diabetic macular oedema.

Authors:  A Koytak; M Altinisik; E Sogutlu Sari; O Artunay; J C Umurhan Akkan; K Tuncer
Journal:  Eye (Lond)       Date:  2013-03-08       Impact factor: 3.775

5.  Bevacizumab for the management of diabetic macular edema.

Authors:  Francisco Rosa Stefanini; J Fernando Arevalo; Maurício Maia
Journal:  World J Diabetes       Date:  2013-04-15

6.  Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.

Authors:  Min Woo Kim; Haein Moon; Sung Jae Yang; Soo Geun Joe
Journal:  Korean J Ophthalmol       Date:  2016-01-21

7.  Correlation between retinal sensitivity and cystoid space characteristics in diabetic macular edema.

Authors:  Swetha B Velaga; Muneeswar G Nittala; B Parinitha; S R Sadda; Jay Kumar Chhablani
Journal:  Indian J Ophthalmol       Date:  2016-06       Impact factor: 1.848

8.  Intravitreal bevacizumab injections for diabetic macular edema - predictors of response: a retrospective study.

Authors:  Lavnish Joshi; Asaf Bar; Oren Tomkins-Netzer; Satish Yaganti; Jiten Morarji; Panayiotis Vouzounis; Sophie Seguin-Greenstein; Simon R Taylor; Sue Lightman
Journal:  Clin Ophthalmol       Date:  2016-10-21

9.  Clinical Characteristics of Patients with Newly Diagnosed Diabetic Macular Edema in Turkey: A Real-Life Registry Study-TURK-DEM.

Authors:  Bora Eldem; Sengul Ozdek; Ali Osman Saatci; Emin Ozmert; Esat Ulay; Gulsah Nomak
Journal:  J Ophthalmol       Date:  2017-02-19       Impact factor: 1.909

10.  Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema.

Authors:  Bushra Mushtaq; Niall J Crosby; Antonios T Dimopoulos; Peck Lin Lip; Panagiota Stavrou; Samer El-Sherbiny; Yit Yang
Journal:  Clin Ophthalmol       Date:  2014-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.